Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

232 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Macrophages in multiple myeloma: emerging concepts and therapeutic implications.
Asimakopoulos F, Kim J, Denu RA, Hope C, Jensen JL, Ollar SJ, Hebron E, Flanagan C, Callander N, Hematti P. Asimakopoulos F, et al. Among authors: hope c. Leuk Lymphoma. 2013 Oct;54(10):2112-21. doi: 10.3109/10428194.2013.778409. Epub 2013 Apr 11. Leuk Lymphoma. 2013. PMID: 23432691 Free PMC article. Review.
TPL2 kinase regulates the inflammatory milieu of the myeloma niche.
Hope C, Ollar SJ, Heninger E, Hebron E, Jensen JL, Kim J, Maroulakou I, Miyamoto S, Leith C, Yang DT, Callander N, Hematti P, Chesi M, Bergsagel PL, Asimakopoulos F. Hope C, et al. Blood. 2014 May 22;123(21):3305-15. doi: 10.1182/blood-2014-02-554071. Epub 2014 Apr 10. Blood. 2014. PMID: 24723682 Free PMC article.
Tumoricidal Effects of Macrophage-Activating Immunotherapy in a Murine Model of Relapsed/Refractory Multiple Myeloma.
Jensen JL, Rakhmilevich A, Heninger E, Broman AT, Hope C, Phan F, Miyamoto S, Maroulakou I, Callander N, Hematti P, Chesi M, Bergsagel PL, Sondel P, Asimakopoulos F. Jensen JL, et al. Among authors: hope c. Cancer Immunol Res. 2015 Aug;3(8):881-90. doi: 10.1158/2326-6066.CIR-15-0025-T. Epub 2015 May 4. Cancer Immunol Res. 2015. PMID: 25941352 Free PMC article.
Deploying myeloid cells against myeloma.
Jensen JL, Hope C, Asimakopoulos F. Jensen JL, et al. Among authors: hope c. Oncoimmunology. 2015 Dec 10;5(3):e1090076. doi: 10.1080/2162402X.2015.1090076. eCollection 2016 Mar. Oncoimmunology. 2015. PMID: 27141348 Free PMC article.
Immunoregulatory roles of versican proteolysis in the myeloma microenvironment.
Hope C, Foulcer S, Jagodinsky J, Chen SX, Jensen JL, Patel S, Leith C, Maroulakou I, Callander N, Miyamoto S, Hematti P, Apte SS, Asimakopoulos F. Hope C, et al. Blood. 2016 Aug 4;128(5):680-5. doi: 10.1182/blood-2016-03-705780. Epub 2016 Jun 3. Blood. 2016. PMID: 27259980 Free PMC article.
Versican proteolysis predicts immune effector infiltration and post-transplant survival in myeloma.
Dhakal B, Pagenkopf A, Mushtaq MU, Cunningham AM, Flietner E, Morrow Z, Papadas A, Hope C, Leith C, Hematti P, Hari P, Callander NS, Asimakopoulos F. Dhakal B, et al. Among authors: hope c. Leuk Lymphoma. 2019 Oct;60(10):2558-2562. doi: 10.1080/10428194.2019.1585836. Epub 2019 Mar 8. Leuk Lymphoma. 2019. PMID: 30845856 Free PMC article. No abstract available.
Hyaluronan and proteoglycan link protein 1 (HAPLN1) activates bortezomib-resistant NF-κB activity and increases drug resistance in multiple myeloma.
Huynh M, Pak C, Markovina S, Callander NS, Chng KS, Wuerzberger-Davis SM, Bakshi DD, Kink JA, Hematti P, Hope C, Asimakopoulos F, Rui L, Miyamoto S. Huynh M, et al. Among authors: hope c. J Biol Chem. 2018 Feb 16;293(7):2452-2465. doi: 10.1074/jbc.RA117.000667. Epub 2017 Dec 26. J Biol Chem. 2018. PMID: 29279332 Free PMC article.
232 results